Exploring Tisotumab Vedotin in Frontline Cervical Cancer

Time: 9:30 am
day: Day Two

Details:

  • Showcasing Tisotumab Vedotin data from the innovaTV 204 clinical trial
  • Discussing emerging Tisotumab Vedotin data as a frontline treatment
  • Exploring how Tisotumab Vedotin has the possibility as a frontline treatment for cervical cancer

Speakers: